4P-Pharma is delighted to welcome Mathilde Mérot appointed Director of Regulatory Affairs and Clinical Operations.
She has ten years of experience and a background in Pharma and Biotech companies. Her expertise will complement ours to develop and bring curative therapies for serious untreated diseases to patients.
About Mathilde Mérot
Mathilde Mérot started her career in clinical operations at MSD France, where she worked on several clinical trials, mainly in oncology and infectious diseases.
In 2017, she joined the Regulatory Affairs department of INVENTIVA, a Dijon-based biopharmaceutical company specialized in fibrosis, lysosomal diseases and oncology. She has worked on the international development of several molecules and the international management of their clinical trials.
2022, Mathilde joined POXEL, a Lyon-based biopharmaceutical company specialized in metabolic diseases. There, she was responsible for the regulatory side of clinical trials and helped set up the European regulatory strategy for the development of several drug candidates in NASH (non-alcoholic steatohepatitis) and orphan diseases.
At 4P-Pharma, Mathilde Mérot will supervise the clinical team (internal and external) and determine the regulatory strategies for the registration of the various drug candidates.
For more information: PR-Mathilde Merot-pdf
